SARS-CoV-2 Genotyping Highlights the Challenges in Spike Protein Drift Independent of Other Essential Proteins
Authors:
- Jeremy W. ProkopJPJeremy W. Prokop
- Sheryl AlbertaSASheryl Alberta
- Martin Witteveen-LaneMWMartin Witteveen-Lane
- Samantha PellSPSamantha Pell
- Hosam A. FaragHFHosam A. Farag
- Disha BhargavaDBDisha Bhargava
- Robert M. VaughanRVRobert M. Vaughan
- Austin FrischAFAustin Frisch
- Jacob BaussJBJacob Bauss
- Humza BhattiHBHumza Bhatti
- Sanjana AroraSASanjana Arora
- Charitha SubrahmanyaCSCharitha Subrahmanya
Open Access
- 9 September 2024
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 12 (9) , 1863
Abstract
As of 2024, SARS-CoV-2 continues to propagate and drift as an endemic virus, impacting healthcare for years. The largest sequencing initiative for any species was initiated to combat the virus, tracking changes over time at a full virus base-pair resolution. The SARS-CoV-2 sequencing represents a unique opportunity to understand selective pressures and viral evolution but requires cross-disciplinary approaches from epidemiology to functional protein biology. Within this work, we integrate a two-year genotyping window with structural biology to explore the selective pressures of SARS-CoV-2 on protein insights. Although genotype and the Spike (Surface Glycoprotein) protein continue to drift, most SARS-CoV-2 proteins have had few amino acid alterations. Within Spike, the high drift rate of amino acids involved in antibody evasion also corresponds to changes within the ACE2 binding pocket that have undergone multiple changes that maintain functional binding. The genotyping suggests selective pressure for receptor specificity that could also confer changes in viral risk. Mapping of amino acid changes to the structures of the SARS-CoV-2 co-transcriptional complex (nsp7-nsp14), nsp3 (papain-like protease), and nsp5 (cysteine protease) proteins suggest they remain critical factors for drug development that will be sustainable, unlike those strategies targeting Spike.Keywords
Funding Information
- MI-SAPPHIRE
This publication has 55 references indexed in Scilit:
- Emerging drug design strategies in anti-influenza drug discoveryActa Pharmaceutica Sinica B, 2023
- Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysisAntiviral Research, 2022
- SARS-CoV-2 Variants of Concern in the United States—Challenges and OpportunitiesJAMA, 2021
- Gene duplication as a major force in evolutionJournal of Genetics, 2013
- Structural biology of dengue virus enzymes: Towards rational design of therapeuticsAntiviral Research, 2012
- Structural biology of hepatitis C virusHepatology, 2004
- Viral immune evasion: a masterpiece of evolutionImmunogenetics, 2002
- Increasing the precision of comparative models with YASARA NOVA—a self‐parameterizing force fieldProteins: Structure, Function, and Bioinformatics, 2002
- Structural biology of HIV 1 1Edited by P. E. WrightJournal of Molecular Biology, 1999
- Cell surface proteins and malignant transformationBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1976